Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells

Journal of Cellular Biochemistry

Volumn 67, Issue 1, 1997, Pages 55-65

  Liang, Yu Chih ^a   Lin shiau, Shoei Yn ^a   Chen, Chieh Fu ^b   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

( ) Epigallocatechin gallate; Epidermal growth factor receptor; Fibroblast growth factor; Platelet derived growth factor; Protein kinase A; Protein kinase C; Protein tyrosine kinases; Receptor tyrosine kinases

Indexed keywords

EPIGALLOCATECHIN GALLATE; POLYPHENOL;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CATECHIN; CELL DIVISION; DNA, NEOPLASM; EPIDERMAL GROWTH FACTOR; HUMANS; LIGANDS; PHOSPHOTYROSINE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; TEA; TUMOR CELLS, CULTURED;

EID: 0030930265     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V     Document Type: Article

References (37)

1. Osawa T (1992): In Huang MT, Ho CT, Lee CY (eds): Phenolic anti-oxidants in dietary plants as antimutagens. Washington, DC: American Chemical Society, pp 135-149.
2. Katiyar S, Kagarwal R, Zain MT, Mukntar H (1993): Protection against N-nitrosodiethylamine and benzo[a-]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 14:849-855.
3. Ho CT, Chen Q, Shi H, Zhang KQ, Rosen RT (1992): Antioxidative effect of polyphenol extract prepared from various chinese teas. Prev Med 21:520-525.
4. Nakamura M, Kawabata T (1981): Effect of Japanese green tea on nitrosamine formation in vitro. J Food Sci 46:306-307.
5. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H (1995): Incorporation of 5-bromo-2′-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res 5:2081-2084.
6. Shi ST, Wang ZT, Smith TJ, Hong JY, Chen WF, Ho CT, Yang CS (1994): In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by x-ray. Cancer Res 54:4641-4647.
7. Lea MA, Xiao Q, Sadhuknan AK, Cottle S, Wang ZY, Yang CS (1993): Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 68:231-236.
8. Nishida H, Omori M, Fukntomi Y, Ninomiya M, Nishiwaki S, Suganuma M, Moriwaki H, Muto Y (1994): Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNcryj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn J Cancer Res 85:221-225.
9. Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H, Yang CS, Conney AH (1992): Inhibitory effect of topical application of green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 13:947-954.
10. Yoshizawa S, Horiuchi T, Suganuma M (1992): In Huang MT, Ho CT, Lee CY (eds): Penta-O-galloyl-β-D-glucose and (-)epigallocatechin gallate. Washington, DC: American Chemical Society, pp 316-325.
11. Katiyar SK, Agarawal R, Wood GS, Mukhtar H (1992): Inhibition of 12-O-tetradecanoylphorbol-13-acetate caused tumor promotion in 7,12-dimethylbenz [a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res 52: 6890-6897.
12. Lin YL, Juan IM, Chen YL, Liang YC, Lin JK (1996): Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with antiproliferative actions in fibroblast cells. J Agric Food Chem 44:1387-1394.
13. Carpenter G (1987): Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56:881-914.
14. Gill GN, Bertics PJ, Santon JB (1987): Epidermal growth factor and its receptor. Mol Cell Endocrinol 51:169-186.
15. Panayotu G, Waterfied MD (1993): The assembly of signalling complexes by receptor tyrosine kinases. Bioessays 15:171-177.
16. Ullrich A, Schlessinger J (1990): Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
17. Nicholson S, Richard J, Sainsbury C, Halcrow P, Kelly P, Angus B, Wright C, Henry J, Farndon JR, Harris AL (1991): Epidermal growth factor receptor (EGFr): Results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 63:146-150.
18. Atlas I, Mendelsohn J, Baselga J, Masui H, Fair WR, Kumar R (1992): Growth regulation of human renal carcinoma cells: Role of transforming growth factor alpha. Cancer Res 52:3335-3339.
19. Mukaida H, Toi H, Hiral T, Yamashita Y, Toge T (1991): Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 68:142-148.
20. Davis RJ, Czech MP (1985): Amiloride directly inhibits growth factor receptor tyrosine kinase activity. J Biol Chem 260:2543-2551.
21. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-i, Itoh N, Shibuya M, Fukami Y (1987): Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
22. Geahlen RL, Koonchanok NM, McLaughlin JL (1989): Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds. J Natl Prod 52:982-986.
23. Nonaka GI, Kawahara O, Nishioka I (1983): Tannins and related compounds. XV. A new class of dimeric flavan-3-ol gallates, theasinensins A and B, and proanthocyanidin gallates from green tea leaf. Chem Pharm Bull 31:3906-3914.
24. Huang YT, Kuo ML, Liu JY, Huang SY, Lin JK (1996): Inhibitions of protein kinase C and proto-oncogene expression in NIH 3T3 cells by apigenin. Eur J Cancer 32A:146-151.
25. src tyrosine kinase activation. Free Radical Biol Med 21:437-448.
26. Liu JY, Lin SJ, Lin JK (1993): Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14:857-861.
27. Kumar R, Atlas I (1992): Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: Role in growth regulation. Proc Natl Acad Sci USA 89:6599-6603.
28. Cooper JA, Sefton BM, Hunter T (1983): Detection and quantification of phosphotyrosine in proteins. Methods Enzymol 99:387-402.
29. Richert ND, Willingham MC, Pastan I (1983): A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen. J Biol Chem 258:8902-8907.
30. Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ (1995): Frequent expression of a mutant epidermal growth factor in multiple human tumors. Cancer Res 55:5536-5539.
31. Yang CS, Wang ZY (1993): Tea and cancer. J Natl Cancer Inst 85:1038-1049.
32. Wakshull EM, Wharton W (1985): Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis. Proc Natl Acad Sci USA 82:8513-8517.
33. Bacus SS, Stancovski I, Huberman E, Chin D, Hurwitz E, Mills GB, Ullrich A, Sela M, Yarden Y (1992): Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res 52:2580-2589.
34. Betsholtz C, Johnsson A, Heldin CH, Westermark B (1986): Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA 83: 6440-6444.
35. Hawking F (1978): Suramin: With special reference to onchocerciasis. Adv Pharmacol Chemother 15:289-322.
36. Cushman M, Nagarathnam D, Burg DL, Geahlen RL (1991): Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J Med Chem 34:798-806.
37. Levitzki A, Gazit A (1995): Tyrosine kinase inhibition: An approach to drug development. Science 267:1782-1788.